Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: gao seng who wrote (498)	6/27/2000 7:35:00 PM
From: gao seng	Respond to of 746

Asked if Celera might consider some day developing its own therapeutic vaccines against cancer, he said: ``We haven't ruled anything out at this point.'' Therapeutic vaccines are used to stimulate the body's immune system to fight specific diseases, including cancer May be one good reason why IMNR had a nice day. I also like RZYM has a natural to benefit from genome assembly. Gene shears are pretty cool way to fix a lot of genetic abnormalities. And VLTS is doing great work with Interleukin, as well as others. I think this statement is very significant, and possibly could mean they are looking to buy a company or two. Give them some products to market a lot sooner than everyone expects. And with their name of the product, it has got to be good.